Post Translational Modifications in Tolerance and Autoimmunity
Post Translational Modifications in Tolerance and Autoimmunity
批准号:
8240037
负责人:
Mark J Mamula
金额:
$40.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-04-01 至 2014-09-30
关键词:
AffectAnimal ModelAnimalsAntibodiesApoptosisAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmune ResponsesAutoimmunityB-LymphocytesBiochemicalBypassCD4 Positive T LymphocytesCellsCellular StressChromatinCitrullineCytoplasmic ProteinDevelopmentDiagnosticDiseaseEnzymesEpitopesEukaryotic CellFrequenciesFundingGoalsHistocompatibility Antigens Class IIHistone H2BHistonesHumanHuman CharacteristicsImmuneImmune ToleranceImmune responseImmune systemImmunityImmunizationIndividualInflammationInvadedKnock-in MouseKnockout MiceKu70 proteinLaboratoriesLupusLymphocyteLymphocyte FunctionManuscriptsMethylationModelingModificationMouse StrainsMusNuclearNuclear ProteinsPathologyPatientsPeptide HydrolasesPeptidesPeripheralPhysiologicalPost-Translational Protein ProcessingProcessPropertyProteinsProto-Oncogene Proteins c-aktRegulatory T-LymphocyteRheumatismRheumatoid ArthritisRibonucleoproteinsRoleSignal TransductionSignaling MoleculeSmall Nuclear RibonucleoproteinsStressSyndromeSystemSystemic Lupus ErythematosusT-Cell ActivationT-LymphocyteT-Lymphocyte SubsetsTemperatureTextTimeTissuesTransferaseWorkabstractingagedantigen processingautoreactive T cellcell typeclinically relevantimmunogenicityin vivolupus-likenovelpathogenprogramsrepairedresponsesystemic autoimmune disease
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The present proposal is a revised, competing continuation of AR48120, "Post-
Translational Modifications in Tolerance and Autoimmunity". Our original proposal
detailed a novel property of self proteins that may confer autoimmune responses in
murine models of systemic lupus erythematosus (SLE). As introduced in our original
proposal, a post-translational protein modification, termed isoaspartyl, can occur
spontaneously under physiologic conditions of pH and temperature. While the
modification has been known to exist in cells for many years now, the immunity to such
modifications within self proteins has only been described by our laboratory. These
modifications occur in all cell types and are enhanced in aged and stressed
lymphocytes. With relevance to our work, autoantibodies to other protein modifications,
notably citrulline proteins, have become diagnostic for autoimmune syndromes such as
rheumatoid arthritis. The overall intent of this proposal is to determine how
spontanteous biochemical modifications within self proteins can change the immunologic
tolerance that is normally established to self proteins. We have identified how two
important mechanisms of protein modification can elicit autoimmunity. First, isoaspartyl
modified self antigens can undergo altered antigen processing, potentially leading to the
expression of novel cryptic self peptides. In particular, histone H2B protein undergoes
extensive isoaspartyl modification that may trigger autoimmunity in this manner.
Second, an accumulation of intracellular protein modifications is found in the cells of
lupus-prone MRL mice causing abnormal T cell hyperproliferation and is coincident with
the onset of autoimmune pathology.
The present proposal will examine the mechanisms of how isoaspartyl protein
modifications alter immunogenicity of proteins and alter lymphocyte functions. In
particular, we will develop novel mouse strains with conditional protein repair systems
that alter protein modification in CD4 T cells. We will determine how autoantigen
processing is altered in the presence of protein modification and how modified histone
protein triggers autoantibody responses. The overall goal of these studies are to identify
the roles of posttranslational protein modifications in the genesis of lupus-like
autoimmunity. Project Narrative
Systemic autoimmune diseases are characterized by aberrant immune responses
directed at a select group in intracellular proteins. The focus of our work is to identify
novel posttranslational protein modifications that may be critical in the induction of
autoimmune disease. Precedence for these studies is apparent by the diagnostic and
clinical relevance of several protein modifications, notably citrulline, in rheumatic
disease. The present studies focus on a protein modification termed `isoaspartyl' that
occurs spontaneously in eukaryotic cells and is enhanced in conditions of cellular stress
and inflammation. We have previously identified the presence of isoaspartyl
modifications in two lupus autoantigens, the snRNP ribonucleoprotein and histone H2B.
We will examine the immunogenicity that arises in the context of this modification and
determine how the course of autoimmunity is altered when isoaspartyl protein
modifications are repaired in vivo. The goal of this work is to determine the importance
of spontaneous protein modification in B and T cell immune tolerance and autoimmune
pathology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multiplexed Bioassay for Checkpoint Inhibitor Autoimmunity
-
批准号:9909591
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2019
-
负责人:Mark J Mamula
-
依托单位:
EGFR Peptides as Vaccines in Anti-Tumor Immunity
-
批准号:8647974
-
项目类别:
-
资助金额:$26.29万
-
财政年份:2013
-
负责人:Mark J Mamula
-
依托单位:
In Vito Imaging
-
批准号:7673607
-
项目类别:
-
资助金额:$19.92万
-
财政年份:2008
-
负责人:Mark J Mamula
-
依托单位:
Mechanisms of Antigen Trafficking in Autoimmunity
-
批准号:7680476
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2008
-
负责人:Mark J Mamula
-
依托单位:
EGFR Peptides as Vaccines in Anti-Tumor Immunity
-
批准号:7330500
-
项目类别:
-
资助金额:$27.77万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
EGFR Peptides as Vaccines in Anti-Tumor Immunity
-
批准号:8150350
-
项目类别:
-
资助金额:$48.94万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
Mechanisms of Antigen Trafficking in Autoimmunity
-
批准号:7352535
-
项目类别:
-
资助金额:$4.13万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
In Vito Imaging
-
批准号:7352530
-
项目类别:
-
资助金额:$13.18万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
EGFR Peptides as Vaccines in Anti-Tumor Immunity
-
批准号:8000852
-
项目类别:
-
资助金额:$62.87万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
Modified HER-2 Tumor Antigens for Vaccination in Cancer
-
批准号:6742316
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2004
-
负责人:Mark J Mamula
-
依托单位:
Modified HER-2 Tumor Antigens for Vaccination in Cancer
-
批准号:7288356
-
项目类别:
-
资助金额:$57.48万
-
财政年份:2004
-
负责人:Mark J Mamula
-
依托单位:
Modified HER-2 Tumor Antigens for Vaccination in Cancer
-
批准号:7158302
-
项目类别:
-
资助金额:$55.29万
-
财政年份:2004
-
负责人:Mark J Mamula
-
依托单位:
Isoaspartyl Modified Tumor Antigens for Vaccination
-
批准号:6840749
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2004
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications and Autoimmunity
-
批准号:6337076
-
项目类别:
-
资助金额:$19.08万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications and Autoimmunity
-
批准号:6877090
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications and Autoimmunity
-
批准号:6511529
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications in Tolerance and Autoimmunity
-
批准号:7464321
-
项目类别:
-
资助金额:$41.34万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications in Tolerance and Autoimmunity
-
批准号:8971933
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications and Autoimmunity
-
批准号:6632440
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
ROLE OF SELF PEPTIDES IN TOLERANCE AND AUTOIMMUNITY
-
批准号:6484674
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
海外基金